ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
scaffold_7_25 # 19865 # 20104 # -1 # ID=7_25;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.579	scaffold_7_25 	19865	20104	-	Strict	850	22.7126	opmE	100.0	3003700	protein homolog model	n/a	n/a	macrolide antibiotic; carbapenem; tetracycline antibiotic; acridine dye; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and intercalating dyes	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACTGGGCCGGAGGTGGTTGCTATCAAAGAGCCACCACCGGTTGTCACCATCACCACGTACCAGGCTATCGCGGTTGAAGAATTCCTTCCCCGCGGTGGCAAGACCTCTTGCACACCAATCTGCGCCGGCGTGATCAGATACTCTTTTTTAAAGAGCCCCCTGGCGCAAGTTTCAGCGTGCTCGCCGGACGCTTACTATTCCTCACCTAGGCAAGCTCCCTACCCGAGCGCCATGTGA	MTGPEVVAIKEPPPVVTITTYQAIAVEEFLPRGGKTSCTPICAGVIRYSFLKSPLAQVSACSPDAYYSSPRQAPYPSAM	MKPYLRSSLSALILLGGCAAVGPDYAPPSASAPASFGAMPAGIDGSGVEIEWWRGFDEPALESLIQRALAANLDIALAGARLDEAKALLRENREEFLPRGGPAFDYQARRRGEVETPAGQQRDIETYRGALDASWEIDLFGRVRRSVEAAEAQAGSREALLRNVQASVAATVAMSWFQLQGIEAELAVVHDIAGNQRDSLEMVERLVSAGSAHEFDRLRAEALLHNVEAAVPDLERRRAATRNALAVLLAEAPQAFSPPVARASGERLTLRTLGVGDPAGLLARRADIAAAERNLAAATARIGVETAGLYPQVEVRGSIGLVAGNLDALDESGTSFNVLNPVIRWALLDRGRVWARIAASEARAQEALILYDRTVLRALQETDDAFNGYGAAADRLRLRLLEATANREAARLARERFVQGDGEYLDVLEAERSDYLSRRALSIARTEQRLAVVGIYKALGGGWEACAGARRCGVATDDTSPGVARQRDSRS	16.09	gnl|BL_ORD_ID|2064|hsp_num:0	2213	True	loose hit with at least 95 percent identity pushed strict
scaffold_15_113 # 98796 # 98909 # 1 # ID=15_113;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=3-4bp;gc_cont=0.667	scaffold_15_113 	98796	98909	+	Strict	890	19.631	cpxA	100.0	3000830	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGCCCCCCAGGCCCCTGGGCGCACGAGAGCCAGGCCTTGGCGCCCGCTCTGTTTAGACCCCTAAACTGCGCTCCACGGCACCCTGGAAGGTTCCCTACTGCGGTAGTGTAG	MGPPGPWAHESQALAPALFRPLNCAPRHPGRFPTAVV	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS	8.10	gnl|BL_ORD_ID|136|hsp_num:0	152	True	loose hit with at least 95 percent identity pushed strict
scaffold_20_392 # 377714 # 377974 # 1 # ID=20_392;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.544	scaffold_20_392 	377714	377974	+	Strict	1000	23.483	MCR-7.1	100.0	3004517	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGTCTGCTCCCAACGCCACCTACCCTTTTTCCAACACCACGGTGTCCACCGGAGGCGTTGCCGCTCTCTACTACCAGTGTGGTGGCATCAACTGGACCGGCCCTACCAAGTGTGAGACCGGCTCCTACTGCAAGAATCAGAACCCGTTCTACCACCAGTGTGTCGCCGTTGAGGAGGGCACCTATACCAATGCAACTGCCACAGGCTCGAATGGTAAGCTGATAAAGAATGGGTGCCTCCACCATCATTCAGAAATCTAA	MSAPNATYPFSNTTVSTGGVAALYYQCGGINWTGPTKCETGSYCKNQNPFYHQCVAVEEGTYTNATATGSNGKLIKNGCLHHHSEI	MRITLGVMKVNLLLVLFFALVLNWPFFLRFYSVISGLEHVRAGFVISVPLVLLAALNAVFIPFTFRWLLKPFFSLLILTGSIVSYAMLKYGVIFDASMIQNIVETNNSEATSYLNVPVVLWFLLTGVLPMVVLWSLKVRYPANWYKGLAIRAGALAFSLLFVGGVAALYYQDYVSIGRNHRILGKQIVPANYVNGIYKYARDVVFATPIPYQPLGTDAKVVAKGDKPTLMFLVVGETARGKNFSMNGYEKETNPFTSQAGGVISFKDVRSCGTATAVSVPCMFSNMGRKEFDDNRARNSEGLLDVLQRSGVSIFWKENDGGCKGVCDRVPNIEIKPKDHPQFCDKNTCYDEVVLQNLDDEVAQMKGDKLVGFHLIGSHRPPYHQRYPDKPPPFVPDCPRSDIENCSDEELVNTYDNTIRYTDFVIAEMITKLKKYEDKYNTALIYLSDHGESLGAMGLYLHGTPYKFAPDDQTRVPMQVWMSPGFAKEKGMDLNCLQQKAADNRYSHDNLFSSVLGIWDVSTAVYDKQLDIFSQCRTVQ	15.96	gnl|BL_ORD_ID|2741|hsp_num:0	3145	True	loose hit with at least 95 percent identity pushed strict
scaffold_40_57 # 52952 # 53113 # 1 # ID=40_57;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.630	scaffold_40_57 	52952	53113	+	Strict	2000	21.557	adeB	100.0	3000775	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGCACTGTAGCTGAGGTCGAGTCTGGCCGGGCTGCCGGGCTGCGACTGGGGCCGCTAGGCTGGGGCTTTTCTGGGCGTACCAGTGTTGGCCATGACAGGGTAGGAAGTGCGGGAGAGCTAACTCTGAACGTCGTCACCCTGGGGCACTTACACACCTGA	MGTVAEVESGRAAGLRLGPLGWGFSGRTSVGHDRVGSAGELTLNVVTLGHLHT	MSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTINDSVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLPQVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFGAEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQLSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANAVKTAEVVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFLHNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERIMATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSILFSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMMVIFLVITGITFTGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNPDVKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSDVNSSMANSTEGETMAVLPPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNISLKIDREKLSAFGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILNLKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLIAKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLGIFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAKLRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFIFILGAVEKLFSSKKKISS	5.12	gnl|BL_ORD_ID|817|hsp_num:0	866	True	loose hit with at least 95 percent identity pushed strict
scaffold_52_191 # 158154 # 158318 # -1 # ID=52_191;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.479	scaffold_52_191 	158154	158318	-	Strict	300	20.7866	AAC(3)-IXa	100.0	3002543	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGTTCATCCAAGAGAACCCCCCTTGGAACAACCTGCCCTGGGATCATCCCCTGATACAATTCACTGGGAATTGTCTGGAATACCAAGTCGAATCATCATTCCTGCTGTCCACAAAACGTAGTATTTTGCAAACCTGTGAGTTTCCGAATCGGGTGGGCCAGTAA	MFIQENPPWNNLPWDHPLIQFTGNCLEYQVESSFLLSTKRSILQTCEFPNRVGQ	MEEMSLLNHSGGPVTRSRIKHDLADLGLKDGDVVIFHTRMSAIGYVAGGTQTIIGALLDVVGARGTLMVPCGWNNAPPYDFLDWPRDWQDALRAEHPAYDPDLSEADYNNGRLPEALPRWPGAIRSRHPDASFAALGPAAAELMAEHPWDHPHGPDTPLARLIAHSGRVLLLGAPLDTMTLLHHAEALADVRSKRFVTYEQPILVNGQRVWRQFRDIDSEEGAFDYSTVRRGVEPFEAIARDMLSAGIGRQGRVGAADSYLFDAGPVFNFAINWIEAKLKR	19.22	gnl|BL_ORD_ID|1915|hsp_num:0	2030	True	loose hit with at least 95 percent identity pushed strict
scaffold_58_49 # 38906 # 39052 # 1 # ID=58_49;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.429	scaffold_58_49 	38906	39052	+	Strict	500	20.0162	mphC	100.0	3000319	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGCACCAAGAAGTGCAGTATTTGGGTCATGAGGTTACGAACTGGCTGGAAAATGATGAACTACTGGCTCAGGACGAGCTATGTTTGTACACAATACAATACGAAATCTGTGCGCCATGCTGCGTGTCAAAATTATTTTGGGAGTAA	MHQEVQYLGHEVTNWLENDELLAQDELCLYTIQYEICAPCCVSKLFWE	MTRHNEIIKCAEKYQLHIQPQTISLNESGLDFQVAFGKDKHGVEWVLRLPRRPDVYKRTKPEKQTVDFLQKNVSFEVPKWKVHERDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPLPENFINTLAETLVDLHNIPEENINVQHINIKTIQEIKNDFQRRMNKVKETYGVSDELWNRWKQWLENDELWPRHATMIHGDLHPGHIMVDNQANVTGLIDWTEATHSDPSMDFMGHHRVFDDEGLEQLITAYGKAGGEIWPRMKEHIIELNAVFPMFIAEFAMESGESAYETMALKELGMKE	16.05	gnl|BL_ORD_ID|1945|hsp_num:0	2062	True	loose hit with at least 95 percent identity pushed strict
scaffold_68_177 # 163980 # 164168 # 1 # ID=68_177;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.513	scaffold_68_177 	163980	164168	+	Strict	450	21.1718	APH(3'')-Ic	100.0	3002640	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	ATGCCAGAACAGCAACTGACGTCTTGCTGTCATGGTGATCTGTGTGCCGGGGATAAGCTTGCCCCATTATTTCCTGTGGTGCATGTACCGACTGCCGACAACATAGGCATCCCGAGATACACAAAAGGCACATGCAGCAAGGTGCTTGGCAGTACCTCATTCATGGGTGAGTTTTGGGCTGCATCATGA	MPEQQLTSCCHGDLCAGDKLAPLFPVVHVPTADNIGIPRYTKGTCSKVLGSTSFMGEFWAAS	MTEWLPVTRGESGAGVFRNSDGSSYAKVVDAAAVADLAAERDRVSWAHRHGVPGPAVIDWRVTEDGGACLITSTVRGVAADRLSESALRAAWPAIVEAVRTLHALPADGCPYRRDLDDMLARARAVVGAGAVNPEFLSDEDREVPAEALLDRVEREADLRRREEAADWVVCHGDLCLPNILVDPDRHTVEGFIDLGRLGLADRHADLALLLANTADTVPGFAEEATAGLAAGYPAQVDPERLRFYLALDPLTWG	24.41	gnl|BL_ORD_ID|1935|hsp_num:0	2052	True	loose hit with at least 95 percent identity pushed strict
scaffold_104_18 # 16453 # 16590 # 1 # ID=104_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.500	scaffold_104_18 	16453	16590	+	Strict	300	20.7866	dfrC	100.0	3002865	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGTTCACTAGTTATCTCCTCCCTAACCGGGTAGTCTACCTATGCATCTCGGGACCGTTGGGCTTGGCACCGAACGACCTCAAGCACGTACTTTTCCCCCACGCTGATAACATCGCATACACAGAAGCATTCCTATAA	MFTSYLLPNRVVYLCISGPLGLAPNDLKHVLFPHADNIAYTEAFL	MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHVKQLTTGNTLVMGRKTFNSIGKPLPNRRNVVLTNQASFHHEGVDVINSLDEIKELSGHVFIFGGQTLFEAMIDQVDDMYITVIDGKFQGDTFFPPYTFENWEVESSVEGQLDEKNTIPHTFLHLVRRKGK	27.95	gnl|BL_ORD_ID|1312|hsp_num:0	1397	True	loose hit with at least 95 percent identity pushed strict
scaffold_105_40 # 32880 # 33059 # 1 # ID=105_40;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.656	scaffold_105_40 	32880	33059	+	Strict	500	20.7866	OXA-53	100.0	3001810	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGGCTCGATGGGCTGGTGGGCTGCCAAAGACCGGGGGGGACCACACTCTGGCCCTTCCACCCGGCCGGGATTCGAGATATCGCCCGAACCTGTGGCTACCGCCTGGCGCTGCGCTGGCAGTTTGGCAGTCTGCGAGCTATGGCCTCCTGCGGCTACCCCGGCTGGCTATGATATGTGA	MGSMGWWAAKDRGGPHSGPSTRPGFEISPEPVATAWRCAGSLAVCELWPPAATPAGYDM	MAIQIFAILFSTFVLATFAHAQDGTLERSDWGKFFSDFQAKGTIVVADERQADHAILVFDQARSMKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVKRSFAGHNKDQDLRSAMRNSTVWVYELFAKEIGDGKARRYLKQIGYGNADPSTSHGDYWIEGSLAISAQEQIAFLRKLYQNDLPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGSMGWWVGWVEWPTGPVFFALNIDTPNRMDDLFKREAIARAILLSIEALPPNPAVHSDAAR	21.45	gnl|BL_ORD_ID|1263|hsp_num:0	1341	True	loose hit with at least 95 percent identity pushed strict
scaffold_105_62 # 49173 # 49364 # -1 # ID=105_62;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.552	scaffold_105_62 	49173	49364	-	Strict	800	22.3274	OprN	100.0	3000805	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAACCCCAACGAGGCCCAGGCGACGCAATACGTGACGCCGGAGGCACTAAAGAAGCAGTTTGACGACCCGACACTCAAGTTCACACCATGGTTCAAGCTCATCTGCAACTCTATGCTTTTCGAGTGGTGGTCGCACCTGGACTCGGGCCTGGAAGCCTATAAGAACGAGCAGCAGATTCGACGCATGTGA	MNPNEAQATQYVTPEALKKQFDDPTLKFTPWFKLICNSMLFEWWSHLDSGLEAYKNEQQIRRM	MIHAQSIRSGLASALGLFSLLALSACTVGPDYRTPDTAAAKIDATASKPYDRSRFESLWWKQFDDPTLNQLVEQSLSGNRDLRVAFARLRAARALRDDVANDRFPVVTSRASADIGKGQQPGVTEDRVNSERYDLGLDSAWELDLFGRIRRQLESSDALSEAAEADLQQLQVSLIAELVDAYGQLRGAQLREKIALSNLENQKESRQLTEQLRDAGVGAELDVLRADARLAATAASVPQLQAEAERARHRIATLLGQRPEELTVDLSPRDLPAITKALPIGDPGELLRRRPDIRAAERRLAASTADVGVATADLFPRVSLSGFLGFTAGRGSQIGSSAARAWSVGPSISWAAFDLGSVRARLRGAKADADAALASYEQQVLLALEESANAFSDYGKRQERLVSLVRQSEASRAAAQQAAIRYREGTTDFLVLLDAEREQLSAEDAQAQAEVELYRGIVAIYRSLGGGWQPSA	13.35	gnl|BL_ORD_ID|304|hsp_num:0	172	True	loose hit with at least 95 percent identity pushed strict
scaffold_133_161 # 137122 # 137274 # 1 # ID=133_161;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.471	scaffold_133_161 	137122	137274	+	Strict	500	20.4014	L1 beta-lactamase	100.0	3000582	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	L1 family beta-lactamase	ATGAGTGACGATGGAAAGGAAGGGGTCATGGTGGCGTTTCGTGGGTTTGGGGAGTTAGACAGCGGATTTGAGCTATCACAAATGCTTGAGTATGAAATACCTGACCCAAAAATGTCGTCATGTTCGCCTTGTGATCTCTTGTTGACGTGGTAG	MSDDGKEGVMVAFRGFGELDSGFELSQMLEYEIPDPKMSSCSPCDLLLTW	MRSTLLAFALSSLALAATLFTFDGAAADASLPQLQAYTVDPSWLQTMAPLQIADHTWQIGTHDLTALLVQTADGLVLIDGGMPQMASYLLTNMKARGTNTGPLRMVLLSHAHTDHAGPVAEIKRRTGAQVVVNAETAVLLARGGSDDLHFGDEITFPPVNADRIVMDREVVKLGGIAFTAHFMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVRGLPCDLLLTPHPGASNWNYAAGSNASEKVLSCKAYADAAEKKFDAQLAKETAGAR	16.95	gnl|BL_ORD_ID|1520|hsp_num:0	1619	True	loose hit with at least 95 percent identity pushed strict
scaffold_137_2 # 2082 # 2255 # -1 # ID=137_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.638	scaffold_137_2 	2082	2255	-	Strict	700	22.7126	ACC-3	100.0	3001817	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam	antibiotic inactivation	ACC beta-lactamase	ATGCTGCGTGATGCAGTTGGCGAGATATGGTTGGCGGCAGCCCGGTGCTGCTGGCAGCTAAGAGGTGAGGTGGGCCATGCTGGACCATGCTGGACCCTGTCGCTGCGATGTCACCGATATGACGGCGACTTGTGTGGAAGCCCACCCCTCCCCCCCCAGGAGGAGGCTGGGTGA	MLRDAVGEIWLAAARCCWQLRGEVGHAGPCWTLSLRCHRYDGDLCGSPPLPPQEEAG	MRKKMQNTLKMLSVITCLALTAQGAMASEMDQAKIKDTVDSLIQPLMQKNNIPGMSVAVTLNGKNYIYNYGLASKQPQQPVTDNTLFEVGSLSKTFAATLASYAQVSGKLSLDKSISHYVPELRGSSFDHISVLNAGTHTTGLALFMPEEVKNTDQLMAYLKAWKPADPAGTHRVYSNIGTGLLGMIAAQSMGMTYEDAIEKTLLPKLGMTHTYLNVPADQAENYAWGYNKKNEPIHVNMEVLGNEAYGIRTNASDLIRYVQANMGQLKLDGNSTLQKALTDTHIGYFKSGKITQDLMWEQLPYPVSLPDLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKMGIVMLANKNYSIDQRVT	15.12	gnl|BL_ORD_ID|1337|hsp_num:0	1422	True	loose hit with at least 95 percent identity pushed strict
scaffold_137_102 # 91529 # 91663 # -1 # ID=137_102;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.585	scaffold_137_102 	91529	91663	-	Strict	400	20.0162	QnrVC7	100.0	3003193	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic target protection	quinolone resistance protein (qnr)	GTGAGACACTGGATCAGGGGAGTGGATCTGCAGAGTCTGTATCACAGGTTCACTGAGCTCACCGTCATCAACCAGTCCGACCATCTACACGATTCCGAGGGCTGCTGGAGCGTGCCGGGGAGAGGAGAGGCATGA	MRHWIRGVDLQSLYHRFTELTVINQSDHLHDSEGCWSVPGRGEA	MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD	20.18	gnl|BL_ORD_ID|1756|hsp_num:0	1859	True	loose hit with at least 95 percent identity pushed strict
scaffold_142_352 # 290516 # 290707 # -1 # ID=142_352;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.552	scaffold_142_352 	290516	290707	-	Strict	2000	21.1718	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	100.0	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGCAAGATGCCGGTCTGTCCAGCTGGGGTTCAGAATCCGGGCCGCTGCCAGATTACGAACACACCAAGATAAAAATTGGTCGCCTTACCAACGGCCCACATGAAACATACTTCATGTGCCCTGCCAGTTTAGGCTGGATAGCACATGCCCACCCTCCCATGTGCGGTGGGCTAGCCTGGCTAGATACCTAG	MQDAGLSSWGSESGPLPDYEHTKIKIGRLTNGPHETYFMCPASLGWIAHAHPPMCGGLAWLDT	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	5.31	gnl|BL_ORD_ID|2668|hsp_num:0	2914	True	loose hit with at least 95 percent identity pushed strict
scaffold_212_37 # 27571 # 27711 # 1 # ID=212_37;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.574	scaffold_212_37 	27571	27711	+	Strict	500	20.7866	AAC(3)-IVb	100.0	3005061	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGGGTGACGAGGGCTTGGCTGAGGTCCTCGAGTGGCCGCTGGATTGTGACCGTGTGTGGGAGGAGCTTGCCGAAGGGTATGGTTGCGAGGAGTGCGATTTTGAGGTGATTGGAGGCGGTCTTGAGGTCTTCATGTTGTAG	MGDEGLAEVLEWPLDCDRVWEELAEGYGCEECDFEVIGGGLEVFML	MVTQLRALGVPPGAVLLVHASFRSIRPVQGGPQGLIEALREAAGPAGTLVMPSWGDDDDAPFDPAATPAAADLGAVADAFWRLPDVVRSHHPFAFAAAGPQAHRITADPLPLPPHIPASPVGRVHELDGQVLLLGVGHDANTTIHLAELMAGVPYGVPHHCTVLRDGKPARIDYLENDHCCQRFDLVDGWLKEKGLQREGPVGNAGARLMRARDIVDVVRQQLARDPLVFLHPPQVGCEECDAARRSVSTK	18.33	gnl|BL_ORD_ID|2846|hsp_num:0	3801	True	loose hit with at least 95 percent identity pushed strict
scaffold_213_19 # 12423 # 12767 # -1 # ID=213_19;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.562	scaffold_213_19 	12423	12767	-	Strict	1300	23.8682	mecB	100.0	3003440	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGAGTGCGGGATGGGAGGGTAGTTTCGTGGGCATGTATTGGTGCAGTGGCAAGGAAGGGGACCCGGGACAGAGGAACAGTTCGTGGGGGGGGGGGGGGGGTGGCAGGTCTCCCCTGGGCCAGGCAATTGGAGAAGTAGCTGTAAGTGACACTCGTCGGAAATGCAGGAGATGTGGTGGAGCGATGGAAGATGAAGAAAGGAGGGAGGGAGTCGGTGTCCTGAAGGAGGAATGCCATTTATCTCTGCGTCGCGCCCTTCAGAATATGCCACGTCCGAGTACATATGGCATGGCCAAGGATAGTATACGCCTTGAGGTGCTCATTTTGGAATTTTCGTCCCGGTGA	MSAGWEGSFVGMYWCSGKEGDPGQRNSSWGGGGGGRSPLGQAIGEVAVSDTRRKCRRCGGAMEDEERREGVGVLKEECHLSLRRALQNMPRPSTYGMAKDSIRLEVLILEFSSR	MKNKALAILIICICLLIAYNFVKKDEVDKIFDAIELRDSEYLNEHATFLSKSLYDKDQRYKRMDKIDASLGIKEVKVSNVRLVQKKKNKRQYSANLNFRTKYGNFSREGNYSFEKDEITKKWLLDWSPEVIIPGLTDRNQISIETLESFRGKILDRNGIDIAKDGIHYEVGIDIKNLNKKNKKNISKLLSISESTLNKKLKQTWVKEGVFLPLKSYIELDDELKLGIQKYHLTVNQTKGRVYPLREATVHLLGYVGEINAEELKNKKFKDYDEHSIVGKSGIELQYDKQLQNKDGYKVVITSDDALNNDEDVLLEKKPKNGQDIILTIDSKVQRSIYSHLKEDNGSGVAMNPKTGELLALVSYPAYDPYEFMFGISDENYKKIVNDKKEPLLNKFQTTSSPGSTQKLITSIIGLKNGTIDASTSYNIVTKGWQRNSSWGGYEVTRFEEVNGDIDLEKAIAHSDNIFFARATLDMGSEKFIKGMKALDIGRNIPSDYYFQKGQIANPESLKNNFKNEILLADSGYGQGEILISPVQILSIYSSLINEGKMMKPKLFETTKEDIWKNHIISKDDVDILTRSMRKVVTGTHRLDAERNYAQFAGKTGTAELKTSREEGLGAQIGWFVGYDQNNPNMMLGISVKNVENKGMSSYNARKFAEIMDELYENGTKKYEIDR	16.91	gnl|BL_ORD_ID|1499|hsp_num:0	1595	True	loose hit with at least 95 percent identity pushed strict
scaffold_215_97 # 83619 # 83741 # 1 # ID=215_97;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.463	scaffold_215_97 	83619	83741	+	Strict	400	20.4014	vatB	100.0	3002841	protein homolog model	n/a	n/a	streptogramin antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	ATGCTGTCGCGTATCATCAGAGCTACGTTATGGTGGGACTGGTGTTTATCCTACAGCACCTTGCAGCTTACAGGAAGATCAGTGCATGTGTACACAGGATACACGAATTTGATCACCCTGTAA	MLSRIIRATLWWDWCLSYSTLQLTGRSVHVYTGYTNLITL	MKYGPDPNSIYPHEEIKSVCFIKNTITNPNIIVGDYTYYSDVNGAEKFEEHVTHHYEFRGDKLVIGKFCAIAEGIEFIMNGANHRMNSITTYPFNIMGNGWEKATPSLEDLPFKGDTVVGNDVWIGQNVTVMPGIQIGDGAIVAANSVVTKDVPPYRIIGGNPSRIIKKRFEDELIDYLLQIKWWDWSAQKIFSNLETLCSSDLEKIKSIRD	18.87	gnl|BL_ORD_ID|1122|hsp_num:0	1189	True	loose hit with at least 95 percent identity pushed strict
scaffold_216_173 # 160715 # 160876 # -1 # ID=216_173;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.537	scaffold_216_173 	160715	160876	-	Strict	700	21.557	vanSM	100.0	3002939	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGCAGACGTTTTTGGGACACTTGAAAAGGCCCCCAGCCAGGCATTCCTTCCTGATCTGGCCCGGTGAGCACATCATCCCTCCCAACGAATTACCTCGCCCAGAGATGCCCACACTCACAAGTTTAGCAACTCCATTAACACCCCATTGCGCCTCTATCTGA	MQTFLGHLKRPPARHSFLIWPGEHIIPPNELPRPEMPTLTSLATPLTPHCASI	MAKMRSSFRTKIILLFAVSMLLAGMVTYLLFKGLQLYYHTMIHRGNPLAELRDFIESIGDFNFFFLLFILLSLSVFYILTKPYSAYFDEISTGIQYLALGDFKRRVNIQSNDEFGDIAQAINQASEKLEEAIQRGDFSENSKEQLVVNLAHDLRTPLTSVLGYLDLVLKDEKLTKEQVRHFLTIAFTKSQRLEKLIDELFEITRMNYGMLSIEKKPINLTDLLLQLKEELYPIFEKNGLTARMNTLPHLPVSADGEMLARVFENLLTNANRYGHDGQFVDINGFVDEEEVVVQVVNYGDSIPPNELPYLFDMFYTGDKARTHKEDSTGLGLFIAKNIVEQHNGTVTAESSLIRTVFEVRLPLESAPIDQV	14.32	gnl|BL_ORD_ID|1251|hsp_num:0	1328	True	loose hit with at least 95 percent identity pushed strict
scaffold_218_37 # 54441 # 54626 # -1 # ID=218_37;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.640	scaffold_218_37 	54441	54626	-	Strict	1000	21.557	MCR-9.1	100.0	3004684	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGATCGGCTCCCGGTCGTGTATCGGGAAACACCTCGCCATGATGGAGCTGCGCCTGGCCGGCGCCGTGCTCTTCAGGGAGTGCCGGGGCCTGCGGCTGGCTCCAAGCTGTACGGACGACTCGATGCAGCAGGTCCAGTGGGTGTTCACGGGGCCCAAGGGAGGCAAGTGCGAGATGACTTTCTAG	MIGSRSCIGKHLAMMELRLAGAVLFRECRGLRLAPSCTDDSMQQVQWVFTGPKGGKCEMTF	MPVLFRVKVIPLVLLLAMIFAFLLNWPILLHFYEILSHLEHVKIGFVISIPFVLVAALNVVFMPFSVRFLLKPFFALLFITGSLVSYSTLKYKVMFDQTMIQNIIETNPQEAHSYLNGSIIIWFVFTGILPAILLFSIKIQYPEKWYKGIAYRLLSVLASLSLIAGVAALYYQDYASVGRNNSTLNKEIIPANYAYSTFQYVKDTYFTTKVPFQTLGNDAKRVVAHEKPTLMFLVIGETARSQNFSMNGYSRDTNAFTSKSGGVISFKNMHSCGTATAISVPCMFSNMNRTEYDSKKASNSENFLDIVQKTGVSLLWKENDGGCKGVCSRIPTVEIKPSDNPKLCDGKTCHDEVMLENLDDEIAKMPGDKLVAFHIIGSHGPTYYLRYPAEHRHFMPECARSDIENCTQEQLVNTYDNTLRYTDYVLAEMIEKLKNYSDQYNTVLLYVSDHGESLGESGLYLHGTPYKLAPDQQTHIPMQVWMSPGFIAGKHINMSCLENNAAKKSYSHDNLFSSILGLWDVSTSVYNPDRDLFRECRG	11.32	gnl|BL_ORD_ID|2300|hsp_num:0	3383	True	loose hit with at least 95 percent identity pushed strict
scaffold_237_12 # 19642 # 19737 # -1 # ID=237_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.562	scaffold_237_12 	19642	19737	-	Strict	650	19.2458	vanB	100.0	3000013	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGCTTCTCTACTTCGTGCTATCAGGGATCCCGCTGCCCTTTCACTTGCTTGATCTCGGGAAGCTCCACGAGCCCGTGTCCTACTTGGAGCTTTGA	MLLYFVLSGIPLPFHLLDLGKLHEPVSYLEL	MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWEADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVGCDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGVTKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIFRIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGIVLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR	9.06	gnl|BL_ORD_ID|1031|hsp_num:0	1098	True	loose hit with at least 95 percent identity pushed strict
scaffold_247_123 # 110716 # 110979 # 1 # ID=247_123;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.549	scaffold_247_123 	110716	110979	+	Strict	450	21.557	oxa-647	100.0	3005337	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGGGAGAAAGAGGTGCGCAGCTAGTCAGTACTGTACTGGCTGGCTGACTGGGTGGGCAGGTGCTGCTGCCGTGGTGTTTATTAGCATGGGATTTAGCAACAAATGCATTTGCATTTCCAGCTGTATTTGTATTTCTGGTCCCTCTCCCCGCCGCCCAGCCTGCTCCGTTCCTGCTAACAGCAAGCGCCTACGCCTTGACCGTGACCATGACCATGACATGTACAGTAGCAGACCAGCCGGACCTCTGCGCTACCTACTTTAG	MGRKRCAASQYCTGWLTGWAGAAAVVFISMGFSNKCICISSCICISGPSPRRPACSVPANSKRLRLDRDHDHDMYSSRPAGPLRYLL	MKILILLPLLSCLGLTACSLPVSSLPSPSTSTQAIASLFDQAQSSGVLVIQRDQQVQVYGNDLNRANTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFTAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMQNGIDPAIRLEILQQALAELGLYPKDEG	31.87	gnl|BL_ORD_ID|3108|hsp_num:0	4069	True	loose hit with at least 95 percent identity pushed strict
scaffold_267_145 # 111738 # 111866 # 1 # ID=267_145;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.543	scaffold_267_145 	111738	111866	+	Strict	2000	20.4014	adeB	100.0	3000775	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCATGGGATATGGTCAGACGGCTGGAGGGTTCCAGCCAAGGGTGTTGTGCATGCTGGAACGAAGGGCTGCCGTGGGAGAACGGGAGTGCGGAGGAGTCGTCCACTGCAAATTACAAAATTGTATGA	MSWDMVRRLEGSSQGCCACWNEGLPWENGSAEESSTANYKIV	MSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTINDSVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLPQVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFGAEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQLSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANAVKTAEVVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFLHNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERIMATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSILFSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMMVIFLVITGITFTGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNPDVKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSDVNSSMANSTEGETMAVLPPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNISLKIDREKLSAFGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILNLKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLIAKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLGIFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAKLRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFIFILGAVEKLFSSKKKISS	4.06	gnl|BL_ORD_ID|817|hsp_num:0	866	True	loose hit with at least 95 percent identity pushed strict
scaffold_274_93 # 78077 # 78235 # -1 # ID=274_93;partial=00;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.654	scaffold_274_93 	78077	78235	-	Strict	500	20.7866	TEM-225	100.0	3005256	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	ATGGCTGAGGAACCACGGCGCCACGAGTCGCAGGCAAACGGCAATGCCACCGCCGTTGCGACAGAGTCCGCGAAACCGCTGCCGCCAGGCGTGGTCCTCGGGCCCGACGGGAAGCCGTACGTTGTTCCCAGTCCCGGATCTGGTCTCTGCAACAGCTGA	MAEEPRRHESQANGNATAVATESAKPLPPGVVLGPDGKPYVVPSPGSGLCNS	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTTPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGSRGIIAALGPDGKPSRIVVIYTTGSQVTMDERNRQIAEIGASLIKHW	18.18	gnl|BL_ORD_ID|3027|hsp_num:0	3988	True	loose hit with at least 95 percent identity pushed strict
scaffold_283_86 # 64900 # 65100 # -1 # ID=283_86;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.537	scaffold_283_86 	64900	65100	-	Strict	650	21.1718	clcD	100.0	3004599	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGCCTGACTATGTACCGAGGTACATCACAGACTGGCTCACAGAGGCCGTCAGGGTGTCACAGAGCAAGTTTGGGGGTCATCCCCAGAGGCAGGCTCACTTGTTTTCCAGCATTGGCCAATGCCATGCCTCATCAGCACCACACAAGACTCAGCAAGGACACCAATGTGGCTGCAACTTCGAAAAATGCTCGGGCTGGTGA	MPDYVPRYITDWLTEAVRVSQSKFGGHPQRQAHLFSSIGQCHASSAPHKTQQGHQCGCNFEKCSGW	MQQKNKYIRIQEFLKQNKFPNYRMKQITNAIFPGRINNFNEITVLPKSLRDMLIEEFGESILNIVPLKAQQSTQVSKVLFGISGDEKIETVNMKYKAGWESFCISSQCGCNFGCKFCATGDIGLKRNLTSDEITDQILYFHLQGHSIDSISFMGMGEALANVQVFDALNVLTDPALFALSPRRLSISTIGIIPNIKKLTQNYPQVNLTFSLHSPFNEQRSELMPINERYPLSDVMDTLDEHIRVTSKKVYIAYIMLHGVNDSIEHAKEVVNLLRGRYRSGNLYHVNIIRYNPTISSRMRFEEANEKCLVNFYKELKSAGIKVTIRSQFGIDIDAACGQLYGNYQKTNSQ	18.91	gnl|BL_ORD_ID|2791|hsp_num:0	3300	True	loose hit with at least 95 percent identity pushed strict
scaffold_393_40 # 34250 # 34366 # -1 # ID=393_40;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.427	scaffold_393_40 	34250	34366	-	Strict	1200	20.4014	otr(A)	100.0	3002891	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAACAAGAGTTTTGTCAAATGATTTGGTCTTTGACTCTACAAATGATTCTGTTGCGGGGATTGGTCCATCCCGTGTTGTTGCTGGGACTCCAAGATTTCTCAGTAGTCGCTTAG	MKQEFCQMIWSLTLQMILLRGLVHPVLLLGLQDFSVVA	MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV	5.73	gnl|BL_ORD_ID|1221|hsp_num:0	1273	True	loose hit with at least 95 percent identity pushed strict
scaffold_455_15 # 10575 # 10793 # 1 # ID=455_15;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.566	scaffold_455_15 	10575	10793	+	Strict	700	21.9422	cfr(D)	100.0	3005021	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGTCTCACAGCGTCATCGCAGGGATCGTCATGCGCGATCTGGCCCGCTCCCTATTGGATTCCGGCGCGTCCAGTGGATCGAGGATCACGACGCGCGAGATCTGCGACCCGGAACATAGATGCATCACCTCGCCTACAATCATACCTTTGGCAAACCCCCACTTTGGCCATTCTGATCGAGTATGTCATGATTCCGTCCGGCTTTGCCCCCTAGTGTAG	MSHSVIAGIVMRDLARSLLDSGASSGSRITTREICDPEHRCITSPTIIPLANPHFGHSDRVCHDSVRLCPLV	MLQKQLTKYQQIEKVLKECQQPNYRMKQILHCIFKEKKTDFNEMSVLPKNLRDTLTTEIGTSLLTVEPLIEQKSQQVRKVLFNLSGDNRIETVNMTYQAGWESFCISSQCGCNLGCQFCATGKIGLRKNLTAEEITDQVLYFLLKGHQIDSISFMGMGEPLANPHFFEALDIFMNPDMFQLSPRRLSVSTIGVIPKIKRLTAEYPQVHLTFSLHSPFDEERSQLMPINKSFPLLKVMDTLDEHIKVTSKKVYIAYILLPDVNDSLTHAVALADLLRSRYKKGKLYHVNLIRYNPTFDAPRTFKQVDEKQVKLFYQTLISKGINVTIRSQFGIEIDAACGQLYGNYEIKNKKTIQVND	20.17	gnl|BL_ORD_ID|2812|hsp_num:0	3763	True	loose hit with at least 95 percent identity pushed strict
scaffold_460_9 # 11410 # 11541 # -1 # ID=460_9;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.545	scaffold_460_9 	11410	11541	-	Strict	1000	20.0162	MCR-5.2	100.0	3004698	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGAGGACTGCCCAGGTGGGTTTCTTCGAAAGTTTAGGAGAAAAGGGGTTGGTTTGCTGCGCCGGGGGGGGGGGCATCAGTGTCGTTCTGCAGGTAGGGTTTATTCAGGGTTACGGGGACGAGATGAATTAA	MRTAQVGFFESLGEKGLVCCAGGGGISVVLQVGFIQGYGDEMN	MRLSAFITFLKMRPQVRTEFLTLFISLVFTLLCNGVFWNALLAGRDSLTSGTWLMLLCTGLLITGLQWLLLLLVATRWSVKPLLILLAVMTPAAVYFMRNYGVYLDKAMLRNLMETDVREASELLQWRMLPYLLVAAVSVWWIARVRVLRTGWKQAVMMRSACLAGALAMISMGLWPVMDVLIPTLRENKPLRYLITPANYVISGIRVLTEQASSSADEAREVVAADAHRGPQQGRRPRALVLVVGETVRAANWGLSGYERQTTPELAARDVINFSDVTSCGTDTATSLPCMFSLNGRRDYDERQIRRRESVLHVLNRSDVNILWRDNQSGCKGVCDGLPFENLSSAGHPTLCHGERCLDEILLEGLAEKITTSRSDMLIVLHMLGNHGPAYFQRYPASYRRWSPTCDTTDLASCSHEALVNTYDNAVLYTDHVLARTIDLLSGIRSHDTALLYVSDHGESLGEKGLYLHGIPYVIAPDEQIKVPMIWWQSSQVYADQACMQTHASRAPVSHDHLFHTLLGMFDVKTAAYTPELDLLATCRKGQPQ	7.88	gnl|BL_ORD_ID|2375|hsp_num:0	3396	True	loose hit with at least 95 percent identity pushed strict
scaffold_560_25 # 25839 # 25928 # -1 # ID=560_25;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.600	scaffold_560_25 	25839	25928	-	Strict	850	20.0162	OpmB	100.0	3004072	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATGGGAGGGGGATGGGATGAAGAGCCGGGTCCGCATTTCCCGCAGGACTGGGATGTCAAGGCCGAGGGGTTCACTCCTGGATTATAG	MMGGGWDEEPGPHFPQDWDVKAEGFTPGL	MKHTPSLLALALVAALGGCAIGPDYQRPDLAVPAEFKEAEGWRRAEPRDVFQRGAWWELYGDQTLNDLQMHLERSNQTLAQSVAQFRQAEALVRGARAAFFPSITGNVGKTRSGQGGGDSTVLLPGGSTVSSGGSGAISTSYSTNLSVSWEVDLWGKLRRQLEANQASLHASAADLAAVRLSQQSQLAQNYLQLRVMDEQIRLLNDTVTAYERSLKVAENKYRAGIVTRADVAQARTQLKSTQAQAIDLKYQRAQLEHAIAVLVGLPPAQFNLPPVASVPKLPDLPAVVPSQLLERRPDIASAERKVISANAQIGVAKAAYFPDLTLSAAGGYRSGSLSNWISTPNRFWSIGPQFAMTLFDGGLIGSQVDQAEATYDQTVATYRQTVLDGFREVEDYLVQLSVLDEESGVQREALESAREALRLAENQYKAGTVDYTDVVTNQATALSNERTVLTLLGSRLTASVQLIAAMGGGWDSADIERTDERLGRVEEGLPPSP	5.82	gnl|BL_ORD_ID|2374|hsp_num:0	2716	True	loose hit with at least 95 percent identity pushed strict
scaffold_669_1 # 325 # 414 # -1 # ID=669_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.344	scaffold_669_1 	325	414	-	Strict	400	19.2458	CAM-1	100.0	3004559	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	CAM beta-lactamase	AACCTTTATTACCCTGGTGAAGGTGTACAACAACAGTTACTCTCATATGCAATTAATCATTCCAAAAAGACACTAGTAGCTCACATATAA	NLYYPGEGVQQQLLSYAINHSKKTLVAHI	MKSTAIILFLLVFSLGVFGQTGDALKISQLSGDFYIFTTYQTYKDAKVSANGMYVVTDEGVVLIDTPWDETQLQPLLNYIKEKHNKDVVMSVSTHFHEDRTNGIEFLRTKGVKTYTTKKTDELSQKKGYERAEFLLEKDTEFKIGQYKFQTYYPGEGHAPDNIVVWFPNERILYGGCFIKSTEAEDIGNLSDANIDEWSNSIKNVQKKFKNPKFVIPGHDGWASTKSLKHTLKLIKKTRKK	12.03	gnl|BL_ORD_ID|2768|hsp_num:0	3266	True	loose hit with at least 95 percent identity pushed strict
scaffold_677_12 # 12930 # 13088 # -1 # ID=677_12;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.516	scaffold_677_12 	12930	13088	-	Strict	300	20.4014	dfrK	100.0	3002869	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGAGTGGTAAGGTTGGCCCATACTCCGTCAACAGGGGCCATGAAGTTGTCGCTCTTCCGGGGAGGCGCAACAGTACAGGCATCCTTCTCAAATTGATCCTGAGCCATGGCTCTCTTCGCATGGTTGATATTGATGGGGTCAACAATGTACCCTGCTGA	MSGKVGPYSVNRGHEVVALPGRRNSTGILLKLILSHGSLRMVDIDGVNNVPC	MKVSLIAAMDKNRVLGKENDIPWRIPKDWEYVKNTTKGYPIILGRKNLESIGRALPGRRNIILTRDKGFSFNGCEIVHSIEDVFEICNNEEEIFIFGGEQIYNLFLPYVEKMYITKIHYEFEGDTFFPEVNYEEWSEVSVTQGITDEKNPYTYYFHIYERKAS	31.90	gnl|BL_ORD_ID|1807|hsp_num:0	1913	True	loose hit with at least 95 percent identity pushed strict
scaffold_153_65 # 57135 # 57401 # -1 # ID=153_65;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.498	scaffold_153_65 	57135	57401	-	Strict	300	23.483	Escherichia coli soxR with mutation conferring antibiotic resistance	100.0	3003381	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	antibiotic target alteration; antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTGCATTTTCTGGACGCACTGGGGATCTGGATTCACCTAGACTTTGCCGGTACCCGTGTATATCCCGGCTGGTTTGTTCCGCCACAACTGGGCTGTGTATACTATCAACTGAGACAGCGGTCGAATGCCGAGTCTTCTCATCTCAGCGAAACCTATACATCTCTCATGTTGCTGTGTCTGTCCCGCTCGGACTGTCCGGCTCCGACTATCATCTACTCGACTCTTCTACGTACATGGGTATCTTTAGGTAACGACTTCCACTAA	MLHFLDALGIWIHLDFAGTRVYPGWFVPPQLGCVYYQLRQRSNAESSHLSETYTSLMLLCLSRSDCPAPTIIYSTLLRTWVSLGNDFH	MEKKLPRIKALLTPGEVAKRSGVAVSALHFYESKGLITSIRNSGNQRRYKRDVLRYVAIIKIAQRIGIPLATIGEAFGVLPEGHTLSAKEWKQLSSQWREELDRRIHTLVALRDELDGCIGCGCLSRSDCPLRNPGDRLGEEGTGARLLEDEQN	57.14	gnl|BL_ORD_ID|2024|hsp_num:0	1005	True	loose hit with at least 95 percent identity pushed strict
